AIM
NVO

Anchor Investment Management’s Novo Nordisk NVO Stock Holding History

Anchor Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462K Sell
12,579
-228
-2% -$10.8K 0.04% 274
2025
Q4 		$652K Sell
12,807
-40
-0.3% -$2.04K 0.05% 242
2025
Q3 		$713K Hold
12,847
– – 0.06% 231
2025
Q2 		$887K Sell
12,847
-750
-6% -$51K 0.08% 199
2025
Q1 		$944K Buy
13,597
+150
+1% +$12.4K 0.09% 193
2024
Q4 		$1.16M Hold
13,447
– – 0.11% 172
2024
Q3 		$1.6M Buy
13,447
+297
+2% +$39.6K 0.15% 142
2024
Q2 		$1.88M Buy
13,150
+60
+0.5% +$7.95K 0.19% 121
2024
Q1 		$1.68M Buy
13,090
+266
+2% +$31.7K 0.18% 133
2023
Q4 		$1.33M Sell
12,824
-600
-4% -$59.3K 0.15% 150
2023
Q3 		$1.22M Hold
13,424
– – 0.16% 140
2023
Q2 		$1.09M Buy
13,424
+400
+3% +$32.7K 0.14% 149
2023
Q1 		$1.04M Sell
13,024
-800
-6% -$56.7K 0.14% 156
2022
Q4 		$935K Hold
13,824
– – 0.13% 159
2022
Q3 		$689K Sell
13,824
-1,000
-7% -$53.6K 0.11% 180
2022
Q2 		$826K Hold
14,824
– – 0.12% 169
2022
Q1 		$823K Sell
14,824
-750
-5% -$38.5K 0.1% 185
2021
Q4 		$872K Hold
15,574
– – 0.11% 183
2021
Q3 		$748K Hold
15,574
– – 0.1% 188
2021
Q2 		$652K Hold
15,574
– – 0.09% 203
2021
Q1 		$525K Hold
15,574
– – 0.08% 212
2020
Q4 		$544K Sell
15,574
-1,500
-9% -$51.8K 0.1% 178
2020
Q3 		$593K Hold
17,074
– – 0.12% 157
2020
Q2 		$559K Hold
17,074
– – 0.13% 157
2020
Q1 		$514K Hold
17,074
– – 0.13% 159
2019
Q4 		$494K Sell
17,074
-800
-4% -$22.2K 0.11% 178
2019
Q3 		$462K Hold
17,874
– – 0.11% 182
2019
Q2 		$456K Sell
17,874
-2,000
-10% -$49.4K 0.11% 178
2019
Q1 		$520K Hold
19,874
– – 0.13% 162
2018
Q4 		$458K Sell
19,874
-7,800
-28% -$173K 0.13% 167
2018
Q3 		$652K Sell
27,674
-540
-2% -$13.2K 0.15% 153
2018
Q2 		$651K Hold
28,214
– – 0.16% 146
2018
Q1 		$695K Hold
28,214
– – 0.18% 136
2017
Q4 		$757K Sell
28,214
-1,970
-7% -$50.1K 0.2% 124
2017
Q3 		$727K Buy
30,184
+2,134
+8% +$48.2K 0.21% 115
2017
Q2 		$602K Buy
28,050
+2,150
+8% +$43.4K 0.2% 114
2017
Q1 		$444K Buy
25,900
+4,850
+23% +$84.5K 0.15% 143
2016
Q4 		$377K Buy
21,050
+5,800
+38% +$105K 0.14% 151
2016
Q3 		$317K Hold
15,250
– – 0.12% 177
2016
Q2 		$410K Buy
15,250
+1,000
+7% +$27.4K 0.16% 144
2016
Q1 		$386K Buy
+14,250
New +$382K 0.16% 145

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Anchor Investment Management's NVO Position: Q1 2026 in Review

Anchor Investment Management reduced its Novo Nordisk (NVO) stake by 1.8% in Q1 2026, selling an estimated $10.8K and leaving 12,579 shares worth $462K. The position accounts for 0.04% of the portfolio, ranked #274.

Anchor Investment Management first reported a position in NVO in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.88M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Anchor Investment Management held 12,579 shares of Novo Nordisk worth $462K as of Q1 2026.
  • Anchor Investment Management sold 228 Novo Nordisk shares in Q1 2026, an estimated $10.8K.
  • Novo Nordisk made up 0.04% of Anchor Investment Management's portfolio in Q1 2026, its #274 holding.
  • Anchor Investment Management first reported a position in Novo Nordisk in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Novo Nordisk position peaked at $1.88M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.